Antitumor activity of mutant bacterial cytosine deaminase

World Journal of Gastroenterology

Volumn 17, Issue 24, 2011, Pages 2958-2964

  Deng, Long Ying ^a   Wang, Jian Ping ^a   Gui, Zhi Fu ^a   Shen, Li Zong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

5 fluorocytosine; Bacterial cytosine deaminase; Colon cancer; D314A; Mutant; Suicide gene therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSINE DEAMINASE; FLUCYTOSINE; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM MUTANT; CANCER INHIBITION; CANCER SURVIVAL; COLON CANCER; COLON CARCINOMA; FEMALE; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

EID: 79959683845     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i24.2958     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
2. Weiss J, Moghanaki D, Plastaras JP, Haller DG. Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next? Clin Colorectal Cancer 2009; 8: 194-199
3. Sharma A, Tandon M, Bangari DS, Mittal SK. Adenoviral vector-based strategies for cancer therapy. Curr Drug ther 2009; 4: 117-138
4. Wu C, Lin J, Hong M, Choudhury Y, Balani P, Leung D, Dang LH, Zhao Y, Zeng J, Wang S. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther 2009; 17: 2058-2066
5. Figueiredo ML, Kao C, Wu L. Advances in preclinical investigation of prostate cancer gene therapy. Mol Ther 2007; 15: 1053-1064
6. Chaszczewska-Markowska M, Stebelska K, Sikorski A, Madej J, Opolski A, Ugorski M. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase-for colorectal cancer. Cancer Lett 2008; 262: 164-172
7. Shen LZ, Wu WX, Xu DH, Zheng ZC, Liu XY, Ding Q, Hua YB, Yao K. Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. World J Gastroenterol 2002; 8: 270-275
8. Yazawa K, Fisher WE, Brunicardi FC. Current progress in suicide gene therapy for cancer. World J Surg 2002; 26: 783-789
9. Huang Q, Liu XZ, Kang CS, Wang GX, Zhong Y, Pu PY. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther 2010; 17: 192-202
10. Garcia-Rodríguez L, Abate-Daga D, Rojas A, González JR, Fillat C. E-cadherin contributes to the bystander effect of TK/ GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models. Gene Ther 2011; 18: 73-81
11. Spasojevic I, Maksimovic V, Zakrzewska J, Bacic G. Effects of 5-fluorouracil on erythrocytes in relation to its cardiotoxicity: membrane structure and functioning. J Chem Inf Model 2005; 45: 1680-1685
12. Brown NL, Lemoine NR. Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine. Methods Mol Med 2004; 90: 451-457
13. Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J, DePeralta-Venturina M, Xia X, Brown S, Lu M, Kim JH. Phase I study of replication-competent adenovirus-mediated doublesuicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 2003; 63: 7497-7506
14. Breton E, Goetz C, Kintz J, Accart N, Aubertin G, Grellier B, Erbs P, Rooke R, Constantinesco A, Choquet P. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma. C R Biol 2010; 333: 220-225
15. Shi DZ, Hu WX, Li LX, Chen G, Wei D, Gu PY. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma. Chin Med J (Engl) 2009; 122: 1267-1272
16. Mahan SD, Ireton GC, Stoddard BL, Black ME. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference. Biochemistry 2004; 43: 8957-8964
17. Diasio RB, Lakings DE, Bennett JE. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother 1978; 14: 903-908
18. Stolworthy TS, Korkegian AM, Willmon CL, Ardiani A, Cundiff J, Stoddard BL, Black ME. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine. J Mol Biol 2008; 377: 854-869
19. Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004; 17: 625-633
20. Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther 2007; 14: 1111-1119
21. Kaliberova LN, Della Manna DL, Krendelchtchikova V, Black ME, Buchsbaum DJ, Kaliberov SA. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene. Mol Cancer Ther 2008; 7: 2845-2854
22. Shen LZ, Hua YB, Wu WX, Xu DH, Ding Q, Liu XY, Wang GL. IL-2 gene therapy enhances cytotoxic effect of E. Coli. Cytosine deaminase gene for colon cancer. Zhonghua Weichang Waike Zazhi 2004; 7:411-413
23. Shen LZ, Hua YB, Wu WX, Xu DH, Ding Q, Chen GY, Zheng ZC, Liu XY. Enhancement of tumor killing using a combination of E. Coli. Cytosine deaminase gene and INF- gene therapy. Acta Univ Med Nanjing 2004; 24: 618-620
24. Sun MC, Huang YM, Zhu ZC, Wang JP, Shen LZ, Wu WX. Inhubitory effect of mutant cytosine deaminase D314A against huaman colon cancer cells. Zhongguo Zhongliu Shengwu Zhiliao Zazhi 2009; 16: 595-599
25. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet 2010; 375: 1030-1047
26. Agard C, Ligeza C, Dupas B, Izembart A, El Kouri C, Moullier P, Ferry N. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Cancer Gene Ther 2001; 8: 128-136
27. Shen LZ, Wu WX, Hua YB, Ding Q, Chen T. The relationship between the bystander effect of E. coli cytosine deaminase gene depends on the immune status of host. Linchuang Zhongliuxue Zazhi 2004; 9: 237-240
28. Shen LZ, Ding Q, Wu WX, Xu DH, Liu XY, Zheng ZC, Wu ZY. In vitro effect of cytosine deaminase gene therapy and chemical reagents on colon cancer cell line. Zhonghua Weichang Waike Zazhi 2002; 17: 404-406
29. Xing L, Sun X, Deng X, Kotedia K, Urano M, Koutcher JA, Ling CC, Li GC. Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells. Radiother Oncol 2009; 92: 345-352
30. Escors D, Breckpot K. Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp (Warsz) 2010; 58: 107-119